Contact
Please use this form to send email to PR contact of this press release:
Shaperon Publishes Efficacy of Next-Generation Cancer Immunotherapy in International Journal
TO:
Ellie Jung
Hudson Therapeutics, Inc, US Subsidiary of Shaperon